يعرض 1 - 10 نتائج من 22 نتيجة بحث عن '"human epidermal growth factor receptor 2"', وقت الاستعلام: 1.30s تنقيح النتائج
  1. 1
  2. 2

    المصدر: Breast, Vol 60, Iss, Pp 238-244 (2021)
    The Breast : Official Journal of the European Society of Mastology

  3. 3

    المصدر: Breast, Vol 59, Iss, Pp 144-156 (2021)
    The Breast : Official Journal of the European Society of Mastology

  4. 4

    المصدر: Saudi Journal of Biological Sciences
    Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)

  5. 5

    المصدر: The Breast : Official Journal of the European Society of Mastology
    Breast, Vol 56, Iss, Pp 7-13 (2021)

  6. 6

    المصدر: Breast, Vol 52, Iss, Pp 88-94 (2020)
    The Breast : official journal of the European Society of Mastology

    مصطلحات موضوعية: Oncology, PMRT, post-mastectomy radiotherapy (PMRT), ER, estrogen receptor, Lymphovascular invasion, medicine.medical_treatment, SCC, squamous cell carcinoma, AC, doxorubicin and cyclophosphamide, Cohort Studies, 0302 clinical medicine, Breast cancer, Risk Factors, Recurrence, Squamous cell carcinoma, HER2, human epidermal growth factor receptor 2, 030212 general & internal medicine, Lymph node, Aged, 80 and over, CMF, cyclophosphamide, methotrexate, and 5-fluorouracil, BCSS, breast cancer-specific survival, Incidence (epidemiology), General Medicine, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.anatomical_structure, RFi, recurrence-free interval, 030220 oncology & carcinogenesis, Lymphatic Metastasis, FEC, epirubicin and cyclophosphamide, Carcinoma, Squamous Cell, Female, Original Article, IDC, invasive ductal carcinoma, Mastectomy, PARP, poly (ADP-ribose) polymerase, Adult, medicine.medical_specialty, FAP, 5-FU, cisplatin and doxorubicin, RNI, regional nodal irradiation, Breast Neoplasms, UICC, the Union for International Cancer Control, CTCAE, the Common Terminology Criteria for Adverse Events, lcsh:RC254-282, OS, overall survival, 03 medical and health sciences, Internal medicine, medicine, Humans, EBCTCG, the Early Breast Cancer Trialists’ Collaborative Group, Aged, Retrospective Studies, Radiotherapy, business.industry, Retrospective cohort study, medicine.disease, SEER, the Surveillance, Epidemiology and End Results, Survival Analysis, EGFR, epidermal growth factor receptor, Radiation therapy, PgR, progesterone receptor, Surgery, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, business, Rare disease

  7. 7

    المصدر: Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 10, Pp 1015-1035 (2019)
    Neoplasia (New York, N.Y.)

  8. 8
  9. 9
  10. 10

    المصدر: Computational and Structural Biotechnology Journal, Vol 17, Iss, Pp 447-453 (2019)
    Computational and Structural Biotechnology Journal

    مصطلحات موضوعية: Oncology, IHC, Immunohistochemistry, medicine.medical_treatment, Druggability, PIK3CA, Phosphatidylinositol-4,5-bisphosphate-3-kinase catalytic subunit alpha, Review Article, Biochemistry, Targeted therapy, law.invention, Molecular profiling, DNA, Deoxyribonucleic acid, 0302 clinical medicine, Randomized controlled trial, Structural Biology, law, MEK, Mitogen-activated protein kinase, Medicine, Profiling (information science), mTOR, Mammalian target of Rapamycin, 0303 health sciences, ASCO, American Society of Clinical Oncology, Precision oncology, CISH, Chromogenic in-situ hybridization, Computer Science Applications, 030220 oncology & carcinogenesis, HER2, Human epidermal growth factor receptor 2, MP, Molecular profile, FGFR, Fibroblast growth factor receptor, Abl, Abelson murine leukemia viral oncogene homolog 1, Biotechnology, FISH, Fluorescence in-situ hybridization, medicine.medical_specialty, CGH, Comparative genomic hybridization, lcsh:Biotechnology, Biophysics, 03 medical and health sciences, NCI, National Cancer Institute, CR, Complete response, PFS, Progression-free survival, RAF, Rapidly growing fibrosarcoma - protein, Internal medicine, lcsh:TP248.13-248.65, WES, Whole-exome sequencing, Genetics, In patient, RNA, Ribonucleic acid, 030304 developmental biology, R/R, Refractory/Relapsed, PTEN, Phosphatase and tensin homolog, business.industry, Bcr, Breakpoint cluster region, SD, Stable Disease, MSI, Microsatellite Instability, Personalized medicine, FDA, Food and Drug Administration, NGS, Next generation sequencing, OS, Overall Survival, PR, Partial Response, HR, Hazard Ratio, Relapsed refractory, TTF, Time to treatment failure, Molecular targets, PCR, Polymerase chain reaction, business, ORR, Overall response rate, Metastatic cancer